In its fourth quarter 2024 investor letter, The London Company SMID Cap Strategy emphasized stocks such as Bruker Corporation (NASDAQ:BRKR). Bruker Corporation (NASDAQ:BRKR) focuses on developing ...
CSO of Vertex Pharmaceuticals and a cameo by President Bill Clinton. She also shares industry insights from companies like Illumina, Bruker, and Pixelgen.
Departement of Industrial Chemistry, Addis Ababa Sciences and Technology University, P.O. Box, Addis Ababa 16417, Ethiopia Sustainable Energy Center of Excellence, Addis Ababa Sciences and Technology ...
Bruker Corporation today announced the launch of the VERTEX NEO Platform today with its first product, the VERTEX NEO R. This release marks a continuation of providing high-end Fourier-Transform ...
Latigo Biotherapeutics, a non-opioid pain biotech looking to ride the waves created by Vertex Pharmaceuticals’ pain drug approval last month, is targeting up to … ...
At a time when many life sciences companies are shrinking their workforce, Vertex Pharmaceuticals Inc. has once again grown its team year-over-year. At a time when many life sciences companies are ...
AlgoTx’s mid-stage stumble on Tuesday comes after Vertex earlier this month won the FDA’s approval for Journavx, an inhibitor of the NaV1.8 voltage-gated sodium channel that marks the first new ...
Vertex Pharmaceuticals recently obtained approval for its non-opioid pain medication. The drug could become a blockbuster and a key part of Vertex's portfolio. The stock has been rising in value ...
Good day, and welcome to the Bruker Corporation Fourth Quarter 2024 ... There is a lot of Asia Pacific, Taiwan, Korea, even Japan, other parts of India, which is not specific, but nonetheless ...
(3) Bruker Scientific Instruments (BSI) revenue reflects the sum of the BSI BioSpin, CALID and Nano Segments as presented in our Annual Report on Form 10-K for the year ended December 31 ...
Bruker exceeded both EPS and revenue forecasts for Q4 2024. The company reported a 14.6% year-over-year increase in quarterly revenue. Stock price decreased by 0.77% despite the earnings beat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback